Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Avatrombopag for adults with early versus chronic immune thrombocytopenia.
Am J Hematol. 2024 Feb;99(2):155-162. doi: 10.1002/ajh.27080. Epub 2023 Dec 8.
Am J Hematol. 2024.
PMID: 38063420
Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.
Al-Samkari H.
Al-Samkari H.
J Intern Med. 2023 Dec;294(6):684-686. doi: 10.1111/joim.13713. Epub 2023 Aug 22.
J Intern Med. 2023.
PMID: 37608622
No abstract available.
Item in Clipboard
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia.
Virk ZM, Richardson TL, Al-Samkari H.
Virk ZM, et al.
J Thromb Thrombolysis. 2023 Aug;56(2):355-359. doi: 10.1007/s11239-023-02839-1. Epub 2023 Jun 20.
J Thromb Thrombolysis. 2023.
PMID: 37340288
Item in Clipboard
Cite
Cite